Analysed INNOVATE CORP (VATE:NYSE) News Sources
MediBeacon® Transdermal GFR Monitor and Reusable Sensor Receive CE Mark Under European Medical Device Regulation
31-03-2026
yahoo.com
INNOVATE Corp. to Report Fourth Quarter and Full Year 2025 Results on March 26th
16-03-2026
yahoo.com
Transdermal GFR Article Recognized as One of Five 2025 Editors’ Choice Articles by Journal of the American Society of Nephrology (JASN)
10-02-2026
yahoo.com
Shareholders in INNOVATE (NYSE:VATE) are in the red if they invested five years ago
09-12-2025
yahoo.com
What is the current price of INNOVATE CORP (VATE:NYSE)?
The current price of INNOVATE CORP (VATE:NYSE) is $8.56.
INNOVATE CORP (VATE:NYSE) absolute price change since previous trading day?
The absolute price change of INNOVATE CORP (VATE:NYSE) since the previous trading day is $0.12.
INNOVATE CORP (VATE:NYSE) percentage price change since previous trading day?
The percentage price change of INNOVATE CORP (VATE:NYSE) since the previous trading day is 1.4218%.
What is the most recent average sentiment score for INNOVATE CORP (VATE:NYSE)?
The most recent average sentiment score for INNOVATE CORP (VATE:NYSE) is 83 out of 100.
What is the most recent average sentiment for INNOVATE CORP (VATE:NYSE)?
The most recent sentiment for INNOVATE CORP (VATE:NYSE) is .
SEC-8K** Filing Available For INNOVATE CORP (VATE:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.